Skip to main content

Research News

Crack GPAT — Prepare for GPAT Online 
  • Scaling peritoneal dialysis equitably across India

    A new Advocacy Paper, developed by leading nephrology experts of the country, outlines a roadmap to scale peritoneal dialysis - a simple, home-based treatment for kidney failure across India, ensuring equitable access to treatment for kidney failure, especially for rural and marginalised communities.
  • Vitamin D3 may cut repeat heart attack risk by 50 percent
    A tailored approach of vitamin D3 supplementation in patients who have suffered a heart attack significantly reduces their risk of a second heart attack, a new study from heart researchers at Intermountain Health in Salt Lake City finds.
  • Scientists Engineer First-Ever Recombinant Snake Antivenom
    In a historic leap for global health, an international team of scientists has developed the world’s first genetically engineered, product-ready snake antivenom — a potential game-changer for treating bites from some of Africa’s most lethal snakes, including cobras, mambas, and rinkhals.
  • Ozempic cuts heart risks even without weight loss
    Semaglutide significantly reduced major adverse cardiovascular events in patients with overweight or obesity with cardiovascular disease but without diabetes, as per recent research study conducted by University College London.
  • UK patient first to trial CAR T cell therapy to treat multiple sclerosis
    A multiple sclerosis patient in the UK was the first to receive CAR T cell therapy, invented by UCL researchers, in a clinical trial testing whether this personalised treatment can slow or even halt the progression of the disease.
  • Researchers Identify Perineural Pathway That Fuels HIV Persistence Despite Treatment
    Addressing the question of whether and how immune cells in the central nervous system traffic out, researchers have now identified a perineural pathway through which the HIV virus can redistribute throughout the body.
  • New therapy for active brain metastases successfully tested
    An international clinical study led by the Medical University of Vienna shows that the drug patritumab deruxtecan (HER3-DXd) can have a promising effect in patients with active brain metastases of various tumour types.
  • Lilly's Oral GLP-1, Orforglipron, Demonstrated Superior Glycemic Control in Two Successful Phase 3 Trials
    Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the Phase 3 ACHIEVE-2 and ACHIEVE-5 trials. ACHIEVE-2, the second head-to-head trial in the program, evaluated orforglipron versus dapagliflozin, an SGLT-2 inhibitor, in adults with type 2 diabetes inadequately controlled on metformin.
  • Molecular markers and risk models guide precision care in liver cancer surgery
    Liver cancer remains one of the worlds most lethal cancers, ranking as the third leading cause of cancer-related deaths. Although surgical advances have improved safety, recurrence after hepatectomy continues to be a major challenge.
  • Ateneo scientists research potential anti-ulcer vaccine
    Since ancient times, it was thought that painful stomach ulcers were caused by eating spicy foods or having an unhealthy diet. But since then, researchers have found that Helicobacter pylori a common bacterium found in over 60% of the world’s population—was the real culprit behind most stomach ulcers and a high risk for stomach cancer.
Subscribe to Research News